New implant aims to restore erections after prostate surgery

NCT ID NCT05650866

First seen Mar 19, 2026 · Last updated May 14, 2026 · Updated 5 times

Summary

This study tests a new device implanted during prostate cancer surgery to treat erectile dysfunction. It involves 20 men aged 30-70 who are having nerve-sparing prostatectomy. The device is activated daily, and participants are followed for 6 months to check safety, effectiveness, and satisfaction compared to a control group without the device.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ERECTILE DYSFUNCTION FOLLOWING RADICAL PROSTATECTOMY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Australian Prostate Centre

    RECRUITING

    North Melbourne, Victoria, 3051, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Epworth HealthCare

    ACTIVE_NOT_RECRUITING

    Richmond, Victoria, 3121, Australia

  • Royal Melbourne Hospital

    ACTIVE_NOT_RECRUITING

    Melbourne, Victoria, 3050, Australia

  • St. Vincent's Private Hospital

    ACTIVE_NOT_RECRUITING

    Fitzroy, Victoria, 3065, Australia

Conditions

Explore the condition pages connected to this study.